
Keywords: Myasthenia gravis; Nicotinic acetylcholine receptor; Immunoadsorption; Therapy; Experimental autoimmune myasthenia gravis; MG; myasthenia gravis; EAMG; experimental autoimmune MG; AChR; nicotinic acetylcholine receptor; ECD; extracellular domain; MIR; mai